Aerie Pharmaceuticals recently announced FDA approval for Rhopressa 0.02% for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Rhopressa is a once-daily eye drop that the company says reduces IOP by increasing the outflow of aqueous humor through the trabecular meshwork.

The three clinical trials for Rhopressa demonstrated up to 5 mmHg reductions in IOP for subjects treated once daily in the evening. For patients with baseline IOP <25 mmHg, the IOP reductions with Rhopressa dosed once daily were similar to those with timolol 0.5% dosed twice daily. For patients with baseline IOP equal to or above 25 mmHg, however, Rhopressa resulted in smaller mean IOP reductions at the morning time points than timolol 0.5% for study visits on days 43 and 90; the difference in mean IOP reduction between the two treatment groups was as high as 3 mmHg, favoring timolol.

The most common ocular adverse reaction observed in controlled clinical studies with Rhopressa dosed once daily was conjunctival hyperemia, which was reported in 53 percent of patients.

For more information on Rhopressa, visit

Expanded Parameters for Avaira Vitality Toric
In mid-December, CooperVision announced the nationwide availability of expanded parameters for its Avaira Vitality toric two-week contact lenses, which now include plus powers, high minus powers and a -2.25-D cylinder.

The toric is made from a new silicone hydrogel material (fanfilcon A) and has a high water content and high level of oxygen permeability and transmissibility, the company says. CooperVision adds that the UV protection has also been improved to Class I, which means that the lenses now block more than 90 percent of UVA and 99 percent of UVB rays.

Avaira Vitality toric is now available in a power range of +8 to -10 D, with cylinder options of -0.75, -1.25, -1.75 and -2.25 D in axes from 10 to 180 degrees in 10-degree steps. The base curve is 8.5 mm and the diameter is 14.5 mm.
For more information, visit

Volk Optical’s Next-Gen Lens Cases
Volk Optical has announced the launch of a new case design for its line of diagnostic and therapeutic ophthalmic lenses. It says that
the case enhances the durability and look of its classic case design.

The case has a design that has been engineered to withstand 50,000 openings without hinge breakage, Volk says. There is a thermoplastic rubber insert cushion in the case and a magnetic closure that holds the case shut.

Volk says that its digital series, BIO, slit lamp, laser, surgical and specialty treatment lenses are all available with the new case. The case exteriors are color-coordinated by lens family and clearly labeled with the lens name. The cover plate can also be custom engraved with doctor or practice name. Volk adds that the molded plastic exterior and interior insert are easy to wipe clean. Additionally, the nonslip stabilizing feet hold the case firmly in place.

For more information on Volk’s lens cases, visit